Teng M N, Collins P L
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892-0720, USA.
J Virol. 1998 Jul;72(7):5707-16. doi: 10.1128/JVI.72.7.5707-5716.1998.
We developed a system to identify the viral proteins required for the packaging and passage of human respiratory syncytial virus (RSV) by reconstructing these events with cDNA-encoded components. Plasmids encoding individual RSV proteins, each under the control of a T7 promoter, were cotransfected in various combinations together with a plasmid containing a minigenome into cells infected with a vaccinia virus recombinant expressing T7 RNA polymerase. Supernatants from these cells were passaged onto fresh cells which were then superinfected with RSV. Functional reconstitution of RSV-specific packaging and passage was detected by expression of the reporter gene carried on the minigenome. As expected, the four nucleocapsid proteins N, P, L, and M2-1 failed to direct packaging and passage of the minigenome. Passage was achieved by further addition of plasmids expressing three membrane-associated proteins, M, G, and F; inclusion of the fourth envelope- associated protein, SH, did not alter passage efficiency. Passage was reduced 10- to 20-fold by omission of G and was abrogated by omission of either M or F. Coexpression of the nonstructural NS1 or NS2 protein had little effect on packaging and passage except through indirect effects on RNA synthesis in the initial transfection. The M2-1 transcription elongation factor was not required for the generation of passage-competent particles. However, addition of increasing quantities of M2-1 to the transfection mediated a dose-dependent inhibition of passage which was alleviated by coexpression of the putative negative regulatory factor M2-2. Omission of the L plasmid reduced passage 10- to 20-fold, most likely due to reduced availability of encapsidated minigenomes for packaging. However, the residual level of passage indicated that neither L protein nor the process of RSV-specific RNA synthesis is required for the production and passage of particles. Omission of N or P from the transfection abrogated passage. Thus, the minimum RSV protein requirements for packaging and passaging a minigenome are N, P, M, and F, although the efficiency is greatly increased by addition of L and G.
我们开发了一种系统,通过用cDNA编码的组件重建这些事件来鉴定人呼吸道合胞病毒(RSV)包装和传代所需的病毒蛋白。编码单个RSV蛋白且每个都在T7启动子控制下的质粒,与含有微型基因组的质粒以各种组合共转染到感染了表达T7 RNA聚合酶的痘苗病毒重组体的细胞中。这些细胞的上清液接种到新鲜细胞上,然后用RSV进行超感染。通过微型基因组上携带的报告基因的表达来检测RSV特异性包装和传代的功能重建。正如预期的那样,四种核衣壳蛋白N、P、L和M2-1未能指导微型基因组的包装和传代。通过进一步添加表达三种膜相关蛋白M、G和F的质粒实现了传代;包含第四种包膜相关蛋白SH并没有改变传代效率。缺失G会使传代减少10至20倍,而缺失M或F则会消除传代。非结构蛋白NS1或NS2的共表达对包装和传代几乎没有影响,除非对初始转染中的RNA合成有间接影响。传代能力的颗粒的产生不需要M2-1转录延伸因子。然而,在转染中添加越来越多的M2-1介导了剂量依赖性的传代抑制,而假定的负调节因子M2-2的共表达减轻了这种抑制。缺失L质粒会使传代减少10至20倍,最可能的原因是用于包装的衣壳化微型基因组的可用性降低。然而,传代的残留水平表明,颗粒的产生和传代既不需要L蛋白也不需要RSV特异性RNA合成过程。转染中缺失N或P会消除传代。因此,包装和传代微型基因组所需的RSV蛋白的最低要求是N、P、M和F,尽管添加L和G会大大提高效率。